Health Canada
www.hc-sc.gc.ca
Common menu bar links
Drugs and Health Products
2005
December
- Health Canada advises consumers not to use Kaizen Ephedrine HCL tablets for weight loss [2005-12-28]
- Health Canada advises consumers be cautious when buying Tamiflu online [2005-12-23]
- Important safety information on Paxil (paroxetine) and increased risk of cardiac defects following exposure during first trimester of pregnancy - GlaxoSmithKline Inc.
- For Health Professionals [2005-12-22]
- For the Public [2005-12-22]
- Health Canada warns consumers not to take products containing chaparral [2005-12-22]
- Association of Avandia (rosiglitazone) and Avandamet (rosiglitazone/metformin) with new onset and/or worsening of macular edema - GlaxoSmithKline Inc.
- For Health Professionals [2005-12-21]
- For the Public [2005-12-21]
- Association of Tequin (gatifloxacin) with serious hypoglycemia and hyperglycemia - Bristol-Myers Squibb Canada
- For Health Professionals [2005-12-20]
- For the Public [2005-12-20]
- Health Canada prohibits sale of Bextra in Canada [2005-12-16]
- Important Safety Information on the Association of Zevalin (ibritumomab tiuxetan) with severe mucocutaneous reactions - Berlex Canada Inc.
- Notice to Hospitals [2005-12-09]
- For the Public [2005-12-09]
- Important safety information on pms-Sodium Phosphates Oral Solution with kidney impairment and nephrocalcinosis - Pharmascience Inc.
- For Health Professionals [2005-12-07]
- For the Public [2005-12-07]
- Important safety information on Fleet Phospho-Soda (sodium phosphates oral solution) with kidney impairment and nephrocalcinosis - Johnson & Johnson ○ MERCK Consumer Pharmaceuticals
- For Health Professionals [2005-12-07]
- For the Public [2005-12-07]
- Health Canada warns consumers to return bottles of Euro-ASA 80 mg chewable tablets to place of purchase [2005-12-05]
November
- Important Safety Information on the Association of Aranesp (darbepoetin alfa) with pure red cell aplasia - Amgen Canada Inc.
- For Health Professionals [2005-11-29]
- For the Public [2005-11-29]
- Health Canada clarification on status of Evra contraceptive skin patch in Canada [2005-11-28]
- Important Safety Information on the contraindication of Femara (letrozole) in premenopausal women - Novartis Pharmaceuticals Canada Inc.
- For Health Professionals [2005-11-28]
- For the Public [2005-11-28]
- Health Canada warns consumers not to use certain lots of GenTeal Gel due to potential health risk [2005-11-21]
- Health Canada warns consumers not to use certain lot of Aquify 2-ml Long-Lasting Comfort Drops due to potential health risk [2005-11-18]
- Health Canada warns consumers not to take the Chinese medicine Shortclean due to potential health risk [2005-11-17]
- Potential safety risk regarding the use of Omron 3-way Instant Thermometers [2005-11-10]
- Health Canada advises consumers not to use certain herbal weight loss products from China [2005-11-09]
- Health Canada warns consumers not to use GenTeal Artificial Tears due to potential health risk [2005-11-07]
October
- Health Canada warns consumers not to take Liqiang 4 due to potential health risk [2005-10-25]
- Association of Gamunex (Immune globulin intravenous [Human] 10%) with hemolytic reactions - Talecris Biotherapeutics, Inc. (Bayer Inc., Canadian distributor and importer of the product)
- Notice to Hospitals [2005-10-20]
- For the Public [2005-10-20]
- Important Safety Information on Paxil (paroxetine) and Possible Increased Risk of Birth Defects - GlaxoSmithKline Inc.
- For the Public [2005-10-07]
- For Health Professionals [2005-10-07]
- Safety information about a class of asthma drugs known as long-acting beta-2 agonists [2005-10-04]
September
- Important Safety Information on Strattera (atomoxetine hydrochloride) and the potential for behavioral and emotional changes, including risk of self-harm - Eli Lilly Canada Inc.
- For the Public [2005-09-29]
- For Health Professionals [2005-09-29]
- Traditional kohl products contain lead [2005-09-28]
- Important Safety Information on Celebrex (celecoxib) - Pfizer Canada Inc.
- For Health Professionals [2005-09-21]
- For the Public [2005-09-21]
- Important Safety Information on Certain Blood Glucose Monitors - Abbott Diabetes Care [2005-09-20]
- Important Safety Information on Duragesic (fentanyl transdermal system)
- For Health Professionals [2005-09-16]
- For the Public [2005-09-16]
- Important Safety Information on Thioridazine
- For Health Professionals [2005-09-08]
- For the Public [2005-09-08]
August
- Important Safety Information on Iressa (gefitinib) 250 mg Tablets - AstraZeneca Canada Inc.
- For Health Professionals [2005-08-26]
- For the Public [2005-08-26]
- Health Canada allows Adderall XR back on the Canadian market [2005-08-25]
- Health Canada Advises Consumers About Recall of Counterfeit Lipitor Sold in the United Kingdom [2005-08-15]
- Health Canada warns consumers not to use Sweet-Ease pacifier dip [2005-08-12]
- Updated Renal Safety Information on Zometa (Zoledronic Acid) and Aclasta (Zoledronic Acid) - Novartis Pharmaceuticals Canada inc.
- For Health Professionals [2005-08-09]
- For the Public [2005-08-09]
- Health Canada continues to warn consumers not to use Miracle II Miracle Neutralizer or any other health products from Tedco, Inc. [2005-08-08]
- Health Canada advises Canadians about risks associated with Guidant pacemakers [2005-08-04]
- Potentially fatal interaction between slow-release opioid painkillers and alcohol [2005-08-03]
July
- Important Safety Information on the Concomitant Use of PAXIL (paroxetine hydrochloride) or PAXIL CR (paroxetine hydrochloride controlled release tablets) and pimozide (Orap) Resulting in Arrhythmias (Irregular Heartbeats) - GlaxoSmithKline Inc. [2005-07-29]
- Health Canada advises about vision problems possibly associated with Viagra, Cialis and Levitra [2005-07-26]
- Health Canada warns consumers not to use certain Ayurvedic medicinal products [2005-07-14]
- Health Canada advises consumers about important safety information on statins [2005-07-12]
- Reminder: Canadian Requirements for White Blood Cell Monitoring for Patients Taking Clozaril (clozapine) Tablets - Novartis Pharmaceuticals Canada Inc. [2005-07-07]
- New Safety Information on the Use of DEPO-PROVERA (medroxyprogesterone acetate suspension for injection, 150 mg IM) associated with Bone Mineral Density Changes -Pfizer Canada Inc. [2005-07-04]
June
- Health Canada advises consumers about important safety information on atypical antipsychotic drugs and dementia [2005-06-16]
- Health Canada warns consumers not to use human growth hormone drug called GHR-15 [2005-06-07]
May
- Health Canada warns consumers not to use any natural health products from Master's Miracle. [2005-05-31]
- Health Canada warns consumers not to use any natural health products from Tedco Inc. [2005-05-31]
- Health Canada advises consumers to not use New Choice Pregnancy Test [2005-05-16]
- Update to April 22, 2005 Advisory entitled:"Health Canada advises consumers to verify their medication" [2005-05-12]
- Health Canada Warns Consumers Not to Use "Master's Miracle Fortified Mineral Neutralizer" or "Miracle II Miracle Neutralizer" [2005-05-12]
- Health Canada advises consumers of new warning for DIANE -35 [2005-05-12]
- Health Canada warns consumers not to consume a certain Lot Number of pms-Sodium Polysterene Sulfonate Powder for Suspension [2005-05-02]
April
- Safety Information about Elidel Cream and Protopic Ointment [2005-04-27]
- Health Canada advises consumers to verify their medication [2005-04-22]
- Important Safety Information on certain LifeScan models of blood glucose monitoring systems.-LifeScan [2005-04-21]
- Health Canada has asked Pfizer to suspend sales of its drug Bextra and informs Canadians of new restrictions on the use of Celebrex [2005-04-08]
March
- Health Canada Advises Diabetic Patients Using Extraneal Peritoneal Dialysis Solution About the Risk of Falsely Elevated Blood Glucose Monitor Readings [2005-03-24]
- Fire and Burn Risks Associated with Certain Heating Units for Electrically Heated Blankets [2005-03-14]
- Health Canada Advises Consumers Not to Use "Cough Syrup DM" DIN 02015781 with Lot Numbers Starting with 2J29 and 3J29 [2005-03-14]
- Association of CRESTOR® (rosuvastatin) with muscle related adverse events - AstraZeneca Canada Inc. [2005-03-11]
- Health Canada advises patients about the risks of CRESTOR® (rosuvastatin) [2005-03-07]
- Some Ayurvedic medicinal products reported to contain high levels of heavy metals [2005-03-04]
- Health Canada reminds consumers not to use products containing aristolochic acid [2005-03-03]
February
- Health Canada suspends the market authorization of ADDERALL XR® , a drug prescribed for Attention Deficit Hyperactivity Disorder (ADHD) in children. [2005-02-10]
- Association of Ezetrol (ezetimibe) with myalgia, rhabdomyolysis, hepatitis, pancreatitis, and thrombocytopenia -Merck Frosst/Schering Pharmaceuticals [2005-02-04]
- Update on Safety Information on the LTV Series Ventilators -Pulmonetic Systems, Inc. [2005-02-03]
- Important safety information for patients taking Apo-Mefloquine (mefloquine) for the prevention of malaria. -Apotex Inc. [2005-02-03]
- Important safety information on HUMIRA (adalimumab) - Abbott Laboratories, Limited [2005-02-02]
